Stephen Kanes MD PhD

Stephen Kanes MD PhD began their career as a Psychiatry Resident at Yale University Department of Psychiatry from 1995 to 1999. Stephen then worked as an Assistant Professor of Psychiatry at the University of Pennsylvania from 1999 to 2006. In 2003, they also served as a Consultant for MedCases/IC-AXON until 2006. From 2006 onwards, they joined AstraZeneca, holding various positions including Director-Clinical Research-Discovery Medicine, Group Director-Neuroscience Early Development, and Therapeutic Area Clinical Director (neuroscience). In 2013, they became the Chief Medical Officer at Sage Therapeutics until December 2021. Currently, Stephen Kanes MD PhD is the Chief Executive Officer at EmbarkNeuro since November 2021.

Stephen Kanes MD PhD completed their undergraduate studies from 1982 to 1986 at the University of Pennsylvania, where they obtained a Bachelor of Arts degree in Biological Basis of Behavior, with a focus on Premed. Stephen further pursued higher education from 1987 to 1999, achieving an MD/PhD degree in Medicine and Molecular and Cellular Pharmacology. However, the specific institution from which they completed their MD/PhD degree is not provided.